Metrissa 2 mg
Metrissa 2 mg is a medicine authorised by Swissmedic under authorisation number 67683. The authorisation holder is Gynial AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 March 2020 and the authorisation is valid without a time limit. ATC code G03DB08 places the medicine in the group Sex hormones and modulators of the genital system.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Metrissa 2 mg, Filmtabletten | B | 05 March 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 1 x 28 | Tablette(n) | G03DB08 | 09.99.0. | B |
| 5 | 3 x 28 | Tablette(n) | G03DB08 | 09.99.0. | B |
| 6 | 6 x 28 | Tablette(n) | G03DB08 | 09.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Metrissa 2 mg authorised in Switzerland?
Yes. Metrissa 2 mg is authorised by Swissmedic under authorisation number 67683, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Metrissa 2 mg have?
Metrissa 2 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Metrissa 2 mg?
The authorisation holder is Gynial AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.